David R. Bauer
Lawyers
Filters
ANI Pharmaceuticals $316.25 million convertible notes offering
We advised ANI Pharmaceuticals on the offering
Precigen $34 million follow-on offering
We advised Precigen on the SEC-registered offering
Generation Bio $237 million at-the-market offering
The shares are listed on Nasdaq
MicroStrategy $2 billion at-the-market offering
The stock is listed on the Nasdaq Global Select Market
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
IDEAYA Biosciences $302.5 million equity offering
The common stock is listed on the Nasdaq Global Select Market
InflaRx $75 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Tempus AI $410 million IPO
The stock is listed on the Nasdaq Global Select Market
ProKidney $140 million follow-on offerings
We advised ProKidney on the offering
Medtronic €3 billion notes offering
The notes are due 2029, 2036, 2043 and 2053